NUTX vs ASTH
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Sep 09, 2026
NUTX
ASTH
Investment Advisor Scores
ASTH
AI Analyst Insights
Detailed Metrics Comparison
| Metric | NUTX | ASTH | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 0 | 23.0415 | Tie |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -13.6% | 48.5% | ASTH |
| Earnings Growth | 95.9% | 110.5% | ASTH |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 48.9/100 | 48.9/100 | Tie |
| Profit Margin | 21.2% | 1.1% | NUTX |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
NUTX
MarkupPrice above SMA50, rising 50-day trend (10.7% over 20 days), RSI 62
ASTH
NeutralMixed signals - no dominant trend phase, RSI 47
Fundamentals Snapshot
| Metric | NUTX | ASTH |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 7.2 | 10.7 |
| Trailing P/E | 7.6 | 46.4 |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.1% | 0.5% |
| Gross Margin | 0.5% | 0.1% |
| Operating Margin | 0.6% | 0.0% |
| EPS | 25.81 | 0.82 |
| Dividend Yield | — | — |